Health
World News | Longer Gap in Pfizer-BioNTech COVID Vaccines Boosts Antibody Levels: Study – LatestLY
Get latest articles and stories on World at LatestLY. A longer gap between first and second doses of the Pfizer-BioNTech COVID-19…
London, Jul 24 (PTI) A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with…
Continue Reading
-
Noosa News18 hours agoWoman charged for bomb scare hoax on Brisbane childcare and high school
-
Noosa News22 hours ago‘Guard llama’ Larry killed in dog attack at hobby farm near Geraldton
-
General22 hours agoRelief as disability employment provider Bedford avoids administration
-
Business21 hours agoBroker names 3 ASX small-cap shares with 25%, 35% and 48% upside